Strepsils intensive has a relatively narrow registered footprint, available in seven countries — primarily across Central and Eastern Europe, with two markets further afield in Ireland and South Africa. The brand is not broadly internationalised, and a traveller arriving in Western Europe, the Americas, or most of Asia is unlikely to find this specific product on a pharmacy shelf.
The active ingredient is flurbiprofen, a non-steroidal anti-inflammatory with analgesic and antipyretic properties. Flurbiprofen-containing products are used across a range of pain and inflammation indications, including sore throat-related discomfort, dental pain and toothache, headache and migraine, and musculoskeletal conditions such as back pain, bursitis, osteoarthritis, and ankylosing spondylitis. The structured indication list further down this page details the registered uses in the markets where the product is sold.
Outside its core regional cluster — which includes Poland, Russia, Romania, Bulgaria, and Estonia, alongside Ireland and South Africa — readers will more often encounter flurbiprofen under different brand names, or in different formulations such as throat lozenges, oral tablets, or topical preparations for joint and muscular pain. The non-steroidal anti-inflammatory class as a whole is well represented worldwide under a wide variety of active ingredients and brand names.
A local pharmacist familiar with the regional formulary is the right person to identify a comparable flurbiprofen-containing product or another suitable option in the same class. Regulatory status varies — some flurbiprofen preparations are over-the-counter in certain markets and prescription-only in others — so substitution while travelling is not always a like-for-like exercise. Anyone using this product regularly, or trying to identify a local equivalent abroad, should treat that decision as a conversation with a healthcare provider.
